In this study, we assessed the expression of CX3CR1 and CD200R1 in the early and late stages of chronic progression in intraperitoneal LPS-injected mice and rAAV-hSYN unilaterally injected mice, which are both chronic model of PD, as well as in primary cultured microglia. This evidence concerns the gene CX3CR1 and Parkinson disease.